The Resource Drug class review : final report update 4, Triptans, Mark Helfand, Kim Peterson ; Marian McDonagh, principal investigator, (electronic book)

Drug class review : final report update 4, Triptans, Mark Helfand, Kim Peterson ; Marian McDonagh, principal investigator, (electronic book)

Label
Drug class review : final report update 4, Triptans
Title
Drug class review
Title remainder
final report update 4
Title part
Triptans
Statement of responsibility
Mark Helfand, Kim Peterson ; Marian McDonagh, principal investigator
Title variation
Triptans
Creator
Contributor
Subject
Language
  • eng
  • eng
Summary
Triptans, also called serotonin 5-hydroxytryptamine (5-HT)(1B/1D) agonists, are used to treat migraine and certain other headaches. Triptans act by binding to serotonin receptors in the brain, which leads to a reversal of blood vessel swelling. Triptans may be taken subcutaneously, orally as tablets, capsules, or quick-dissolving wafers, or intranasally as a spray. Currently, 7 triptans are available in the United States (almotriptan, eletriptan, frovatriptan, naratriptan, rizatriptan, sumatriptan and zolmitriptan), as well as a fixed-dose combination product containing sumatriptan plus naproxen. Comparing the clinical efficacy and harms of the different triptans has been an area of considerable interest to researchers and patients, but is complex because of the large variety of outcome measures that can be measured in studies. The purpose of this review is to compare the efficacy, effectiveness, and harms of triptans
Member of
Cataloging source
DNLM
http://library.link/vocab/creatorName
Helfand, Mark
Index
no index present
Literary form
non fiction
Nature of contents
  • dictionaries
  • bibliography
http://library.link/vocab/relatedWorkOrContributorName
  • Peterson, Kim
  • McDonagh, Marian S
Series statement
Drug class reviews
http://library.link/vocab/subjectName
  • Tryptamines
  • Drug Evaluation
  • Evidence-Based Medicine
  • Headache Disorders
  • Headache
  • Clinical Trials as Topic
  • United States
Label
Drug class review : final report update 4, Triptans, Mark Helfand, Kim Peterson ; Marian McDonagh, principal investigator, (electronic book)
Instantiates
Publication
Bibliography note
Includes bibliographical references
Control code
1554797
Dimensions
unknown
Form of item
online
Specific material designation
remote
Label
Drug class review : final report update 4, Triptans, Mark Helfand, Kim Peterson ; Marian McDonagh, principal investigator, (electronic book)
Publication
Bibliography note
Includes bibliographical references
Control code
1554797
Dimensions
unknown
Form of item
online
Specific material designation
remote

Library Locations

Processing Feedback ...